We are live on
!
Find out more
SP
Sarasin & Partners Portfolio holdings
AUM
$8.54B
1-Year Est. Return
9.6%
This Fund
S&P 500
This Quarter
Est. Return
+4.69%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$6.02B
AUM Growth
-$105M
(-1.7%)
Cap. Flow
-$320M
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
33.88%
Holding
138
New
8
Increased
36
Reduced
78
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MBLY
Mobileye N.V.
MBLY
|
+$83.1M |
| 2 |
NextEra Energy
NEE
|
+$73.3M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$64.1M |
| 4 |
United Parcel Service
UPS
|
+$40.3M |
| 5 |
Service Corp International
SCI
|
+$35.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$67.1M |
| 2 |
Hartford Financial Services
HIG
|
+$56.1M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
+$45.5M |
| 4 |
VF Corp
VFC
|
+$43.5M |
| 5 |
Amgen
AMGN
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.95% |
| 2 | Consumer Discretionary | 14.12% |
| 3 | Communication Services | 10.81% |
| 4 | Industrials | 10.37% |
| 5 | Consumer Staples | 9.95% |
Similar funds
PCM
IC
NB
GRQ
ACM
DM
FT
PCIA
Sarasin & Partners's Q2 2016 Portfolio in Review
As of Q2 2016, Sarasin & Partners held 138 positions worth $6.02B, down 1.7% from $6.13B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Sarasin & Partners withdrew a net $320M in Q2 2016, closing 2 positions and reducing 78 holdings. Its most notable exit was Pediatrix Medical, an estimated $1.14M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Sarasin & Partners opened a new position in Mobileye N.V. worth $100M.
- Sarasin & Partners's largest Q2 2016 buy was Mobileye N.V.: 2,170,999 shares worth $100M.
- Sarasin & Partners added most to iShares MSCI ACWI ETF in Q2 2016, an estimated $64.1M increase.
- Sarasin & Partners's biggest Q2 2016 reduction was Walgreens Boots Alliance, cutting an estimated $67.1M.
- Sarasin & Partners fully exited Pediatrix Medical in Q2 2016, selling an estimated $1.14M.
- Sarasin & Partners's ten largest holdings make up 34% of its $6.02B portfolio in Q2 2016.
- Sarasin & Partners opened 8 new positions and closed 2 in Q2 2016.
- Sarasin & Partners's portfolio value fell 1.7% quarter-over-quarter to $6.02B.
Based on Sarasin & Partners's 13F filing for Q2 2016, filed 14 Jul 2016.